The role of microglia in prion diseases and possible therapeutic targets: a literature review

• Published in: Prion Vol. 15; no. 1; pp. 191 - 206
• Main Authors: de Melo, Ananda Sampaio Lamenha Falcão, Lima, Juliana Louise Dias, Malta, Maria Carolina Silva, Marroquim, Natália França, Moreira, Álvaro Rivelli, de Almeida Ladeia, Isabelle, dos Santos Cardoso, Fabrizio, Gonçalves, Daniel Buzaglo, Dutra, Bruna Guimarães, dos Santos, Júlio César Claudino
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.01.2021
• Subjects: Creutzfeldt-Jakob disease; Creutzfeldt-Jakob Syndrome - metabolism; Cytokines - metabolism; Humans; microglia; Microglia - metabolism; neuroinflammation pathways; Prion Diseases - metabolism; Prion Diseases - therapy; Prions - metabolism; Review; microglia; neuroinflammation pathways; Creutzfeldt-Jakob disease
• ISSN: 1933-6896; 1933-690X
• DOI: 10.1080/19336896.2021.1991771

Creutzfeldt-Jakob disease (CJD) is a rare and fatal condition that leads to progressive neurodegeneration due to gliosis, vacuolation of central nervous system tissue, and loss of neurons. Microglia play a crucial role in maintaining Central Nervous System (CNS) homoeostasis, both in health and disease, through phagocytosis and cytokine production. In the context of CJD, the immunomodulatory function of microglia turns it into a cell of particular interest. Microglia would be activated by infectious prion proteins, initially acquiring a phagocytic and anti-inflammatory profile (M2), and producing cytokines such as IL-4, IL-10, and TGF-β. Therefore, microglia are seen as a key target for the development of new treatment approaches, with many emerging strategies to guide it towards a beneficial role upon neuroinflammation, by manipulating its metabolic pathways. In such a setting, many cellular targets in microglia that can be involved in phenotype modulation, such as membrane receptors, have been identified and pointed out as possible targets for further experiments and therapeutic approaches. In this article, we review the major findings about the role of microglia in CJD, including its relationship to some risk factors associated with the development of the disease. Furthermore, considering its central role in neural immunity, we explore microglial connection with other elements of the immune system and cell signalling, such as inflammasomes, the complement and purinergic systems, and the latest finding strategies to guide these cells from harmful to beneficial roles.